The medtech segment achieved operational revenue growth of 4.4% despite ongoing weaknesses in the Chinese market. Notably, ...

The healthcare-products company is taking another shot at resolving mass cancer lawsuits in chapter 11 after two failed ...

There is more to the comparison, and in the sections below, we discuss why we think Disney will outperform J&J in the next ...

Baltimore settled with opioid manufacturer Johnson & Johnson on the eve of its trial against that company and two ...

Johnson & Johnson (NYSE: JNJ) (the “Company”) announced that its subsidiary, Red River Talc LLC (“Red River”), filed a ...

Red River Talc, a Johnson & Johnson subsidiary, filed for Chapter 11 bankruptcy to settle ovarian cancer claims with an $8B ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Johnson & Johnson (JNJ – Research ...

Tenet Media’s six content creators, from left: Benny Johnson, Lauren Southern, Dave Rubin, Tim Pool, Matt Christiansen and Tayler Hansen. (Screenshot from Tenet Media) Radnitz expressed skepticism ...

SINGAPORE, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Johnson & Johnson (J&J), a leading healthcare company, announced its 50th anniversary in Singapore. Guided by Our Credo to put the needs and well ...

In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on Johnson & Johnson (JNJ – Research Report). The ...

Baltimore settled with opioid manufacturer Johnson & Johnson and its subsidiary Janssen Pharmaceuticals on the eve of its trial against that company and two distributors of opioids that the city ...